US FDA Requests Public Comments on L-Tryptophan Products

Summary

The US FDA has issued a notice requesting public comments on the public interest surrounding Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production. The agency is seeking statements from the public on the public interest, following a Final Initial Determination and Recommended Determination on Remedy and Bonding in an ongoing investigation.